These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Comparison of radioimmunoassay and counterimmunoelectrophoresis for the detection of hepatitis B surface antigen carriers in a high-prevalence region. Sandler SG; Knecht A; Amar A; Davidowitch R Isr J Med Sci; 1979 Jul; 15(7):579-82. PubMed ID: 478821 [TBL] [Abstract][Full Text] [Related]
28. [Detection of hepatitis B surface antigen (HBsAg) in patients with pulmonary tuberculosis]. Fondaminskaia LD Probl Tuberk; 1986; (3):25-7. PubMed ID: 3714688 [No Abstract] [Full Text] [Related]
29. [Prevalence of markers of the hepatitis B virus in households of HBs antigen carriers]. Saraux JL; Buffet C; Etienne JP Gastroenterol Clin Biol; 1985 May; 9(5):403-8. PubMed ID: 3891493 [No Abstract] [Full Text] [Related]
30. [Detection of anti-HBc carrier state in blood donors with the Corab kit. Its relationship to anti-HBbrno and hepatitis B virus carrier state]. Pintera J; Krácmar C Cas Lek Cesk; 1980 Sep; 119(36-37):997-1002. PubMed ID: 7438178 [No Abstract] [Full Text] [Related]
31. [The quantitative determination of HBSAG--a valuable aid in evaluating the infectiousness of hepatitis B virus carriers]. Löschner J; Fengler JD; Baumgarten R Z Arztl Fortbild (Jena); 1981 Nov; 75(22):1084-5. PubMed ID: 7340196 [No Abstract] [Full Text] [Related]
32. [e-Antigen and antibody in HBsAg carriers and liver diseases in Taiwan (author's transl)]. Liaw YF; Chang-Chien CS; Huang MJ; Lin DY; Wu CS; Chen PC Taiwan Yi Xue Hui Za Zhi; 1979 Jul; 78(7):635-40. PubMed ID: 291687 [No Abstract] [Full Text] [Related]
33. [Epidemiologic importance of hepatitis B antigen carrier state (author's transl)]. Cervenka J; Fedorová L; Krutý R; Halásová A Bratisl Lek Listy; 1981 Dec; 76(6):641-8. PubMed ID: 7317800 [No Abstract] [Full Text] [Related]
34. Serological markers of hepatitis B infection in Niue children. Williamson HG; Gust ID; Dimitrakakis M; Liu SQ; Taylor R; Whitmore J; Nemaia HT; Nemaia J N Z Med J; 1985 Apr; 98(777):275-7. PubMed ID: 3857507 [TBL] [Abstract][Full Text] [Related]
35. [Importance of the immune system in the symptom-free HBsAg carrier state]. Mansurov KhKh; Asfandiiarova NS Klin Med (Mosk); 1984 Jun; 62(6):17-21. PubMed ID: 6381874 [No Abstract] [Full Text] [Related]
36. [Immunologic aspects of asymptomatic chronic carriers of HBsAg]. Fink de Cabutti NE; Morales VH; Jmlenitzky C; Basualdo Farjat JA; De Torres R Sangre (Barc); 1984; 29(4-A):370-5. PubMed ID: 6505927 [No Abstract] [Full Text] [Related]
37. [An epidemiological study on hepatitis B virus infection in Kaohsiung Medical College freshmen]. Hsieh MY; Lu SN; Chang WY; Wang LY; Chen SC; Chuang WL; Wu CC Gaoxiong Yi Xue Ke Xue Za Zhi; 1987 May; 3(5):318-25. PubMed ID: 3482998 [No Abstract] [Full Text] [Related]
38. Cell-mediated immunity in the evolution of acute and chronic HBsAg hepatitis. Scalise G; Mura MS; Piersimoni C Ann Sclavo; 1981; 23(1):92-105. PubMed ID: 7294920 [No Abstract] [Full Text] [Related]
39. HBsAg immune complexes in the course of infection with hepatitis B virus. Madaliński K; Bragiel I Clin Exp Immunol; 1979 Jun; 36(3):371-8. PubMed ID: 487641 [TBL] [Abstract][Full Text] [Related]
40. [A follow-up study on HBsAg carriers and factors affecting negative-conversion]. Hong DQ Zhonghua Yu Fang Yi Xue Za Zhi; 1984 Jan; 18(1):32-4. PubMed ID: 6468123 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]